View Financial HealthBluGlass 配当と自社株買い配当金 基準チェック /06BluGlass配当金を支払った記録がありません。主要情報n/a配当利回り-14.4%バイバック利回り総株主利回り-14.4%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesNew Risk • Jul 01New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 40% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 9.0% per year over the past 5 years. Shareholders have been substantially diluted in the past year (40% increase in shares outstanding). Minor Risks Revenue is less than US$5m (AU$5.9m revenue, or US$4.0m). Market cap is less than US$100m (AU$62.1m market cap, or US$42.8m).お知らせ • Jun 02BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 1.5 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 1.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 5,769,230 Price\Range: AUD 0.26 Transaction Features: Subsequent Direct ListingBoard Change • May 20No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.New Risk • May 12New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 9.0% per year over the past 5 years. Shareholders have been substantially diluted in the past year (55% increase in shares outstanding). Minor Risks Revenue is less than US$5m (AU$5.9m revenue, or US$4.2m). Market cap is less than US$100m (AU$35.2m market cap, or US$25.5m).Board Change • May 01No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.お知らせ • Apr 15BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 23,500,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 10,100,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Transaction Features: Subsequent Direct ListingBoard Change • Dec 24No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.お知らせ • Oct 18BluGlass Limited, Annual General Meeting, Nov 19, 2025BluGlass Limited, Annual General Meeting, Nov 19, 2025. Location: at the offices of automic group, level 5, 126 phillip street, sydney, nsw 2000 AustraliaReported Earnings • Aug 28Full year 2025 earnings released: AU$0.006 loss per share (vs AU$0.006 loss in FY 2024)Full year 2025 results: AU$0.006 loss per share (in line with FY 2024). Revenue: AU$5.45m (up 18% from FY 2024). Net loss: AU$11.0m (loss widened 8.3% from FY 2024). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings.New Risk • Aug 26New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 19% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 6.7% per year over the past 5 years. Shareholders have been substantially diluted in the past year (41% increase in shares outstanding). Minor Risks Revenue is less than US$5m (AU$5.7m revenue, or US$3.7m). Market cap is less than US$100m (AU$30.9m market cap, or US$20.0m).お知らせ • May 01+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 461,538,462 Price\Range: AUD 0.013 Discount Per Security: AUD 0.00026 Security Features: Attached OptionsBoard Change • Feb 04Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Non-Executive Director Jean-Michel Pelaprat was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Dec 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Non-Executive Director Jean-Michel Pelaprat was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Sep 20BluGlass Limited, Annual General Meeting, Oct 21, 2024BluGlass Limited, Annual General Meeting, Oct 21, 2024. Location: at automic group offices, at level 5, 126 phillip street, sydney, nsw 2000. AustraliaReported Earnings • Aug 28Full year 2024 earnings released: AU$0.006 loss per share (vs AU$0.009 loss in FY 2023)Full year 2024 results: AU$0.006 loss per share (improved from AU$0.009 loss in FY 2023). Revenue: AU$10.1m (up AU$8.94m from FY 2023). Net loss: AU$10.1m (loss narrowed 14% from FY 2023). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.Board Change • Jun 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Non-Executive Director Jean-Michel Pelaprat was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Apr 05BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 157,842,057 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 756,489 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074New Risk • Feb 27New major risk - Revenue and earnings growthEarnings have declined by 4.9% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 4.9% per year over the past 5 years. Revenue is less than US$1m (AU$1.1m revenue, or US$751k). Minor Risks Shareholders have been diluted in the past year (24% increase in shares outstanding). Market cap is less than US$100m (AU$55.0m market cap, or US$36.0m).お知らせ • Feb 20BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,213 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listingお知らせ • Feb 12+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,216 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listingお知らせ • Jan 10BluGlass Limited Announces Management ChangesBluGlass Limited advised that Ms Elizabeth Spooner has resigned as Company Secretary of the Company. Ms Spooner will be replaced by Robyn Slaughter as Company Secretary with effect from 10 January 2024. Robyn is a Company Secretary who works closely with a number of boards of both listed and unlisted public companies across a range of industries including financial services, biotechnology and healthcare, technology, cyber security and manufacturing. Robyn is a qualified Governance Professional (CGI) and Affiliate of the Governance Institute of Australia (GIA), and holds a Master's degree in Corporate Governance and a Bachelor's degree in Accounting and Finance.New Risk • Oct 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 15% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$12m free cash flow). Earnings have declined by 4.9% per year over the past 5 years. Revenue is less than US$1m (AU$1.1m revenue, or US$730k). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (AU$81.0m market cap, or US$51.6m).お知らせ • Sep 13Bluglass Limited Announces Executive ChangesBluGlass Limited has appointed Samuel Samhan as Chief Financial Officer on a full-time basis, effective 11 September 2023. Mr. Samhan is a highly credentialled senior executive with more than 20 years financial leadership and commercial operations experience. He was previously the Chief Operating and Financial Officer at Digital Wellness - a global health platform. Other roles include Head of Commercial and Business Transformation at Vitality Works - Sanitarium Workplace Health and Wellness, and Commercial Manager at Evolution Healthcare Group. He replaces part-time CFO Rob Ambrogio, who resigned from the position to pursue personal projects. To ensure a smooth transition, Mr. Ambrogio will remain with the Company until 29 September 2023. Mr. Samhan holds a Bachelor of Business (Accounting), Master of Business Administration, and is a graduate of the Australian Institute of Company Directors.お知らせ • Sep 08BluGlass Limited, Annual General Meeting, Oct 09, 2023BluGlass Limited, Annual General Meeting, Oct 09, 2023, at 10:01 E. Australia Standard Time. Location: Grant Thornton, Level 17, 383 Kent Street Sydney New South Wales Australia Agenda: To receive and to consider the Annual Financial Report of the Company for the financial year ended 30 June 2023 together with the declaration of the Directors, the Directors' Report, the Remuneration Report and the Auditor's Report for that financial year; to consider Adoption of Remuneration Report; to consider re-election of Directors of the Company; to consider approval of Future Issue of Securities; to consider ratification of Prior Issue of Shares; to consider ratification of Prior Issue of Performance Rights; to consider ratification of Prior Issue of Options; to consider Adoption of Incentive Option & Performance Rights Plan; to consider approval of Issue of Performance Rights to James Walker, Vivek Rao, Stephe Wilks and Jean-Michel Pelaprat Directors of the Company; and to consider approval of Issue of Performance Rights.Reported Earnings • Aug 31Full year 2023 earnings released: AU$0.009 loss per share (vs AU$0.009 loss in FY 2022)Full year 2023 results: AU$0.009 loss per share (in line with FY 2022). Net loss: AU$11.8m (loss widened 26% from FY 2022). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings.New Risk • Aug 27New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$12m free cash flow). Earnings have declined by 7.6% per year over the past 5 years. Revenue is less than US$1m (AU$995k revenue, or US$638k). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (AU$70.3m market cap, or US$45.1m).Reported Earnings • Feb 25First half 2023 earnings released: AU$0.004 loss per share (vs AU$0.005 loss in 1H 2022)First half 2023 results: AU$0.004 loss per share. Net loss: AU$5.36m (loss widened 16% from 1H 2022).お知らせ • Jan 30BluGlass Limited Launches Laser Product Suite at Photonics WestBluGlass Limited has launched its first suite of gallium nitride (GaN) laser products for customer purchase at leading industry conference, SPIE Photonics West, in San Francisco, USA. BluGlass' lasers are available across 405nm, 420nm, and 450nm wavelengths in both single-mode and multi-modedevices. Customers can inspect performance data and purchase these products in a range of form factors including TO Cans of different sizes and Chip-on-Submounts. BluGlass' suite of available products have passed entry-level commercial specifications following significant product development, optimisation, and performance and reliability testing. The following products are now available for customer purchase: Violet 405nm multi-mode 1W laser; Violet 405nm single-mode 250mW laser; Violet 420nm multi-mode 1W laser; Violet 420nm single-mode 250mW laser; Blue 450nm multi-mode 1W laser; Blue 450nm single-mode 100mW laser. The Company has received interest from customers wanting to deploy BluGlass lasers in their product development programs, which span a multitude of applications including; 3D printing, quantum sensing and computing, material sensing, and flow cytometry. In addition to the launched products, laser diode designs in other wavelengths and specifications are progressing through BluGlass' supply chain, including RPCVD-enhanced products.Reported Earnings • Aug 25Full year 2022 earnings released: AU$0.009 loss per share (vs AU$0.009 loss in FY 2021)Full year 2022 results: AU$0.009 loss per share (vs AU$0.009 loss in FY 2021). Net loss: AU$9.36m (loss widened 49% from FY 2021). Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 38% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 24First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: AU$0.005 loss per share (vs AU$0.005 loss in 1H 2021). Net loss: AU$4.62m (loss widened 25% from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 45% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 26Full year 2021 earnings released: AU$0.009 loss per share (vs AU$0.013 loss in FY 2020)Full year 2021 results: Net loss: AU$6.30m (loss widened 5.1% from FY 2020). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 24First half 2021 earnings released: AU$0.005 loss per share (vs AU$0.008 loss in 1H 2020)First half 2021 results: Net loss: AU$3.69m (loss widened 17% from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has fallen by 36% per year, which means it is performing significantly worse than earnings.決済の安定と成長配当データの取得安定した配当: BLGの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: BLGの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場BluGlass 配当利回り対市場BLG 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (BLG)n/a市場下位25% (AU)2.6%市場トップ25% (AU)6.5%業界平均 (Semiconductor)0.6%アナリスト予想 (BLG) (最長3年)n/a注目すべき配当: BLGは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: BLGは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: BLGの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: BLGが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YAU 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/08 22:20終値2026/08/07 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋BluGlass Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Mark BryanCanaccord Genuity Historic (Wilsons Advisory and Stockbroking Ltd.Darren VincentShaw and Partners Limited
New Risk • Jul 01New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 40% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 9.0% per year over the past 5 years. Shareholders have been substantially diluted in the past year (40% increase in shares outstanding). Minor Risks Revenue is less than US$5m (AU$5.9m revenue, or US$4.0m). Market cap is less than US$100m (AU$62.1m market cap, or US$42.8m).
お知らせ • Jun 02BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 1.5 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 1.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 5,769,230 Price\Range: AUD 0.26 Transaction Features: Subsequent Direct Listing
Board Change • May 20No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.
New Risk • May 12New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 9.0% per year over the past 5 years. Shareholders have been substantially diluted in the past year (55% increase in shares outstanding). Minor Risks Revenue is less than US$5m (AU$5.9m revenue, or US$4.2m). Market cap is less than US$100m (AU$35.2m market cap, or US$25.5m).
Board Change • May 01No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.
お知らせ • Apr 15BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 23,500,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 10,100,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
Board Change • Dec 24No independent directorsThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). Member of Industry Advisory Board Steve DenBaars is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors.
お知らせ • Oct 18BluGlass Limited, Annual General Meeting, Nov 19, 2025BluGlass Limited, Annual General Meeting, Nov 19, 2025. Location: at the offices of automic group, level 5, 126 phillip street, sydney, nsw 2000 Australia
Reported Earnings • Aug 28Full year 2025 earnings released: AU$0.006 loss per share (vs AU$0.006 loss in FY 2024)Full year 2025 results: AU$0.006 loss per share (in line with FY 2024). Revenue: AU$5.45m (up 18% from FY 2024). Net loss: AU$11.0m (loss widened 8.3% from FY 2024). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings.
New Risk • Aug 26New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 19% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 6.7% per year over the past 5 years. Shareholders have been substantially diluted in the past year (41% increase in shares outstanding). Minor Risks Revenue is less than US$5m (AU$5.7m revenue, or US$3.7m). Market cap is less than US$100m (AU$30.9m market cap, or US$20.0m).
お知らせ • May 01+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 461,538,462 Price\Range: AUD 0.013 Discount Per Security: AUD 0.00026 Security Features: Attached Options
Board Change • Feb 04Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Non-Executive Director Jean-Michel Pelaprat was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Dec 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Non-Executive Director Jean-Michel Pelaprat was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Sep 20BluGlass Limited, Annual General Meeting, Oct 21, 2024BluGlass Limited, Annual General Meeting, Oct 21, 2024. Location: at automic group offices, at level 5, 126 phillip street, sydney, nsw 2000. Australia
Reported Earnings • Aug 28Full year 2024 earnings released: AU$0.006 loss per share (vs AU$0.009 loss in FY 2023)Full year 2024 results: AU$0.006 loss per share (improved from AU$0.009 loss in FY 2023). Revenue: AU$10.1m (up AU$8.94m from FY 2023). Net loss: AU$10.1m (loss narrowed 14% from FY 2023). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
Board Change • Jun 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Non-Executive Director Jean-Michel Pelaprat was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 05BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 157,842,057 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 756,489 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074
New Risk • Feb 27New major risk - Revenue and earnings growthEarnings have declined by 4.9% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 4.9% per year over the past 5 years. Revenue is less than US$1m (AU$1.1m revenue, or US$751k). Minor Risks Shareholders have been diluted in the past year (24% increase in shares outstanding). Market cap is less than US$100m (AU$55.0m market cap, or US$36.0m).
お知らせ • Feb 20BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,213 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listing
お知らせ • Feb 12+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,216 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listing
お知らせ • Jan 10BluGlass Limited Announces Management ChangesBluGlass Limited advised that Ms Elizabeth Spooner has resigned as Company Secretary of the Company. Ms Spooner will be replaced by Robyn Slaughter as Company Secretary with effect from 10 January 2024. Robyn is a Company Secretary who works closely with a number of boards of both listed and unlisted public companies across a range of industries including financial services, biotechnology and healthcare, technology, cyber security and manufacturing. Robyn is a qualified Governance Professional (CGI) and Affiliate of the Governance Institute of Australia (GIA), and holds a Master's degree in Corporate Governance and a Bachelor's degree in Accounting and Finance.
New Risk • Oct 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 15% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$12m free cash flow). Earnings have declined by 4.9% per year over the past 5 years. Revenue is less than US$1m (AU$1.1m revenue, or US$730k). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (AU$81.0m market cap, or US$51.6m).
お知らせ • Sep 13Bluglass Limited Announces Executive ChangesBluGlass Limited has appointed Samuel Samhan as Chief Financial Officer on a full-time basis, effective 11 September 2023. Mr. Samhan is a highly credentialled senior executive with more than 20 years financial leadership and commercial operations experience. He was previously the Chief Operating and Financial Officer at Digital Wellness - a global health platform. Other roles include Head of Commercial and Business Transformation at Vitality Works - Sanitarium Workplace Health and Wellness, and Commercial Manager at Evolution Healthcare Group. He replaces part-time CFO Rob Ambrogio, who resigned from the position to pursue personal projects. To ensure a smooth transition, Mr. Ambrogio will remain with the Company until 29 September 2023. Mr. Samhan holds a Bachelor of Business (Accounting), Master of Business Administration, and is a graduate of the Australian Institute of Company Directors.
お知らせ • Sep 08BluGlass Limited, Annual General Meeting, Oct 09, 2023BluGlass Limited, Annual General Meeting, Oct 09, 2023, at 10:01 E. Australia Standard Time. Location: Grant Thornton, Level 17, 383 Kent Street Sydney New South Wales Australia Agenda: To receive and to consider the Annual Financial Report of the Company for the financial year ended 30 June 2023 together with the declaration of the Directors, the Directors' Report, the Remuneration Report and the Auditor's Report for that financial year; to consider Adoption of Remuneration Report; to consider re-election of Directors of the Company; to consider approval of Future Issue of Securities; to consider ratification of Prior Issue of Shares; to consider ratification of Prior Issue of Performance Rights; to consider ratification of Prior Issue of Options; to consider Adoption of Incentive Option & Performance Rights Plan; to consider approval of Issue of Performance Rights to James Walker, Vivek Rao, Stephe Wilks and Jean-Michel Pelaprat Directors of the Company; and to consider approval of Issue of Performance Rights.
Reported Earnings • Aug 31Full year 2023 earnings released: AU$0.009 loss per share (vs AU$0.009 loss in FY 2022)Full year 2023 results: AU$0.009 loss per share (in line with FY 2022). Net loss: AU$11.8m (loss widened 26% from FY 2022). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings.
New Risk • Aug 27New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$12m free cash flow). Earnings have declined by 7.6% per year over the past 5 years. Revenue is less than US$1m (AU$995k revenue, or US$638k). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (AU$70.3m market cap, or US$45.1m).
Reported Earnings • Feb 25First half 2023 earnings released: AU$0.004 loss per share (vs AU$0.005 loss in 1H 2022)First half 2023 results: AU$0.004 loss per share. Net loss: AU$5.36m (loss widened 16% from 1H 2022).
お知らせ • Jan 30BluGlass Limited Launches Laser Product Suite at Photonics WestBluGlass Limited has launched its first suite of gallium nitride (GaN) laser products for customer purchase at leading industry conference, SPIE Photonics West, in San Francisco, USA. BluGlass' lasers are available across 405nm, 420nm, and 450nm wavelengths in both single-mode and multi-modedevices. Customers can inspect performance data and purchase these products in a range of form factors including TO Cans of different sizes and Chip-on-Submounts. BluGlass' suite of available products have passed entry-level commercial specifications following significant product development, optimisation, and performance and reliability testing. The following products are now available for customer purchase: Violet 405nm multi-mode 1W laser; Violet 405nm single-mode 250mW laser; Violet 420nm multi-mode 1W laser; Violet 420nm single-mode 250mW laser; Blue 450nm multi-mode 1W laser; Blue 450nm single-mode 100mW laser. The Company has received interest from customers wanting to deploy BluGlass lasers in their product development programs, which span a multitude of applications including; 3D printing, quantum sensing and computing, material sensing, and flow cytometry. In addition to the launched products, laser diode designs in other wavelengths and specifications are progressing through BluGlass' supply chain, including RPCVD-enhanced products.
Reported Earnings • Aug 25Full year 2022 earnings released: AU$0.009 loss per share (vs AU$0.009 loss in FY 2021)Full year 2022 results: AU$0.009 loss per share (vs AU$0.009 loss in FY 2021). Net loss: AU$9.36m (loss widened 49% from FY 2021). Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 38% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 24First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: AU$0.005 loss per share (vs AU$0.005 loss in 1H 2021). Net loss: AU$4.62m (loss widened 25% from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 45% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 26Full year 2021 earnings released: AU$0.009 loss per share (vs AU$0.013 loss in FY 2020)Full year 2021 results: Net loss: AU$6.30m (loss widened 5.1% from FY 2020). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 24First half 2021 earnings released: AU$0.005 loss per share (vs AU$0.008 loss in 1H 2020)First half 2021 results: Net loss: AU$3.69m (loss widened 17% from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has fallen by 36% per year, which means it is performing significantly worse than earnings.